ATG5 and Parkinson disease: Our study indicated that miR-30c-5p overexpression significantly aggravated the neurotoxicity in the PD model, while miR-30c-5p antagomiR could alleviate the damage of dopaminergic neurons through upregulating ATG5 expression.